Clinical Trial Update: Immune Therapy of HPV-induced Cancers [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial update evaluating an immune therapy for HPV-related cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Cervical Cancer
• Oropharyngeal Cancer
• Penile Cancer
• Vaginal Cancer
• Vulvar Cancer

Snippet

Sponsor: Oryx GmbH & Co. KG | Conditions: HPV-induced Cancers | Phase 1, Phase 2 | Status: COMPLETED